
A Chinese consumer has been given the go-ahead to take an “Apple tax” antitrust case to court, as China’s Supreme Court rejected Apple’s call for the lawsuit to be thrown out.
A local report stated that this is a small legal loss, but could have big implications for the Cupertino company.
South China Morning Post (SCMP) reported that China’s Supreme Court has made a civil ruling in favor of a consumer versus the China subsidiary of Apple, in a legal development lawyers say could open the gates for more consumers in the country to file similar complaints against the iPhone maker in local courts.
The case involves Jin Xin, who is demanding Apple stop charging 30% commission on purchases in the China App Store, and to allow Chinese consumers to make payments through wallets other than Apple Pay, to provide 100,000 yuan (US$15,500) in compensation and to issue a public apology.
In his lawsuit Jin alleges that the prices of in-app services offered by apps in Apple’s App Store, including video app iQiyi, podcast app Himalaya, and music app NetEase Music, are higher than in Android app stores – possibly as a result of Apple’s 30%t App store commission. Jin also cites China’s Anti-Monopoly Law in accusing Apple of “anticompetitive” practices.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas